Olema Pharmaceuticals, Inc. (OLMA) - Quarterly Income Statement

Home
OLMA
Financials

4.67 (USD) • At close May 8, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4
Revenue Numbers are in millions	0	0	0	0	1.884	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0	0.094	0.088	0.088	0.09	0.425	0.427	0.423	0.418	0.41	0.407	1.573	0.05	0.031	0.009	0	0	0	0	0
Gross Profit Numbers are in millions	0	0	-0.094	-0.088	1.796	-0.09	-0.425	-0.427	-0.423	-0.418	-0.41	-0.407	-1.573	-0.05	-0.031	-0.009	0	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0	0	0.953	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	32.299	33.226	29.109	29.883	25.872	19.453	17.989	22.826	21.584	17.627	27.054	16.009	15.975	12.523	11.91	10.692	6.289	4.673	1.947	0.795	0.91
General & Administrative Expenses Numbers are in millions	4.469	4.395	4.421	4.456	4.544	3.889	3.612	6.776	5.635	5.595	6.239	7.245	5.782	5.239	4.612	4.758	3.842	3.195	0.539	0.248	0.107
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	-0.088	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	4.469	4.395	4.421	4.456	4.456	3.889	3.612	6.776	5.635	5.595	6.239	7.245	5.782	5.239	4.612	4.758	3.842	3.195	0.539	0.248	0.107
Other Expenses Numbers are in millions	0	0	0	0.017	0.093	-0.079	-0.044	0.011	0.067	-0.12	0.02	0.006	0.01	-0.056	-0.001	0	0	0.001	0	0	0
Operating Expenses Numbers are in millions	36.768	37.621	33.53	34.339	30.328	23.342	21.601	29.602	27.219	23.222	33.293	23.254	21.757	17.762	16.522	15.45	10.131	7.868	2.486	1.043	1.017
Operating Income Numbers are in millions	-36.768	-37.621	-33.53	-34.339	-30.416	-23.342	-21.601	-29.602	-27.219	-23.222	-33.293	-23.254	-21.757	-17.762	-16.522	-15.45	-10.131	-7.868	-2.486	-1.043	-1.017
Operating Income Ratio Numbers are in millions	0	0	0	0	-16.144	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	3.201	3.066	3.148	3.369	3.644	1.84	1.506	1.316	1.04	0.502	0.435	0.224	0.119	0.049	0.116	0.111	0	0.024	0.033	-0.65	0
Income Before Tax Numbers are in millions	-33.567	-34.555	-30.382	-30.97	-26.772	-21.502	-20.095	-28.286	-26.179	-22.72	-32.858	-23.03	-21.638	-17.713	-16.406	-15.339	-10.131	-7.844	-2.453	-1.693	-1.017
Income Before Tax Ratio Numbers are in millions	0	0	0	0	-14.21	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	0	-3.352	4.785	-1.919	-1.55	-1.316	-1.04	-0.502	-0.415	-0.224	-0.063	-0.056	-0.001	0.111	22.117	0.001	0.033	0.003	0
Net Income Numbers are in millions	-33.567	-34.555	-30.382	-30.97	-26.772	-21.502	-20.095	-26.97	-25.139	-22.218	-32.858	-22.806	-21.638	-17.713	-16.406	-15.339	-10.131	-7.844	-2.453	-1.693	-1.017
Net Income Ratio Numbers are in millions	0	0	0	0	-14.21	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-0.57	-0.6	-0.54	-0.56	-0.49	-0.48	-0.49	-0.67	-0.63	-0.55	-0.82	-0.57	-0.54	-0.45	-0.42	-0.39	-0.5	-0.21	-0.17	-0.12	-0.072
EPS Diluted Numbers are in millions	-0.57	-0.6	-0.54	-0.56	-0.49	-0.48	-0.49	-0.67	-0.63	-0.55	-0.82	-0.57	-0.54	-0.45	-0.42	-0.39	-0.5	-0.21	-0.17	-0.12	-0.072
EBITDA Numbers are in millions	-36.652	-37.526	-33.436	-34.251	-30.328	-23.252	-21.502	-29.602	-27.122	-23.131	-33.208	-23.17	-21.565	-17.712	-16.491	-15.441	-10.127	-7.842	-2.451	-1.037	-1.014
EBITDA Ratio Numbers are in millions	0	0	0	0	-16.098	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Olema Pharmaceuticals, Inc.

NASDAQ:OLMA Add to watchlist

NASDAQ:OLMA